Literature DB >> 2857461

Hepatitis B immune globulin to prevent non-A, non-B post-transfusion hepatitis.

U Sugg, W Schneider, H E Hoffmeister, C Huth, W Stephan, R Lissner, W Haase.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857461     DOI： 10.1016/s0140-6736(85)91431-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view.

Authors:  S Abrignani
Journal:  Springer Semin Immunopathol       Date:  1997

Review 2.  Transmission of diseases by blood transfusion.

Authors:  S Seidl; P Kühnl
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

Review 3.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

4.  Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.

Authors:  Zhen-yong Keck; Sophia H Li; Jinming Xia; Thomas von Hahn; Peter Balfe; Jane A McKeating; Jeroen Witteveldt; Arvind H Patel; Harvey Alter; Charles M Rice; Steven K H Foung
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

Review 5.  Neutralizing antibody response to hepatitis C virus.

Authors:  Yong Wang; Zhen-Yong Keck; Steven K H Foung
Journal:  Viruses       Date:  2011-11-02       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.